Why people use Cerebrolysin for stroke recovery
Family member had a stroke. Cerebrolysin in the recovery protocol? The honest answer: yes, there is real clinical evidence here, not just gym-bro consensus. Cerebrolysin is a porcine-brain-derived (made from pig brain tissue) peptide extract approved as a prescription drug in 50+ countries (not the US).
This page covers what's known, what's not, and what the editorial take is for normal humans considering Cerebrolysin for stroke recovery.
What the evidence says
Evidence tier: Strong clinical. Multiple human studies support the dosing protocol; not yet FDA-labeled for this exact indication but close.
- Cerebrolysin is a porcine-brain-derived (made from pig brain tissue) peptide extract approved as a prescription drug in 50+ countries (not the US).
- CARS-1 and CARS-2 trials showed improved motor function recovery in ischemic stroke patients.
- Routinely used in stroke wards in Germany, Russia, China, and parts of Eastern Europe.
Protocol notes
10-30mL IV (intravenous, into a vein) infusion daily for 10-21 days, started within days of the stroke. Hospital or clinic only.
Always with a sports-medicine doctor, telehealth provider, or specialist sign-off. Self-experimenting on injection schedules without clinical input is the most common way people waste money and get hurt.
What to skip
- Vendors without a Certificate of Analysis (COA). Random gym-bro vendors with no third-party testing. The peptide market has a quality-control problem; the answer is COA per peptide, every time.
- Pre-mixed blends from non-pharmacy sources. Compounding pharmacies that produce pre-mixed combinations with COAs are fine. Random vendor "stack vials" are not.
- Massively over-dosed protocols. More is rarely better with peptides. Receptor saturation is real. Stick to evidence-based dosing.
Where to go next
- Full Cerebrolysin directory entry - status, sourcing, studies, what to skip
- What are peptides - if you skipped the foundation
- How peptides actually work - mechanism in plain English
- The Tier List - which ones to take seriously
- Subscribe to the dispatch